Senior Scientific Director - New Jersey, United States - Daiichi Sankyo, Inc.

Description

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.

Under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

The Senior Director, Global Oncology Medical Affairs, Evidence Generation role is responsible for co-leading a cross-functional Evidence Generation Team and developing an Integrated Evidence Plan (IEP) for the assigned compound with a possibility of working in collaboration with a strategic alliance partner.

Co-lead a cross-functional Evidence Generation Team (EGT) for the assigned compound in partnership with Global Health Economics Outcomes Research partner.

As a member of Global Medical Affairs Team (GMAT, or Joint Medical Affairs Team for Alliance compounds) and as a subject matter expert (SME), in alignment with the GMAT Lead, develop an Integrated Evidence Plan (IEP), which includes an evidence gap assessment, gap prioritization and strategic delivery plan.

Communicate progress to relevant internal stakeholders using trackers and tools generated by Global Oncology Medical Affairs Study Operations partners and propose mitigation plans for delayed activities.

Monitor the consistency of IEP process across all asset teams in collaboration with other EG Sr Directors, propose the process modifications and lead the implementation across the asset teams.

• Provide functional excellence expert support and coaching to junior EG team members. PharmD, PhD or MD in scientific discipline required

• Experience developing global or regional medical strategy preferably in lung and/or breast cancer required
• Oncology launch preparation and delivery in Global, Regional or Country Medical Affairs required
• Experience planning and conducting Medical Affairs interventional and noninterventional studies, including Ph 3b/4, EAP, externally sponsored research, external clinical collaborations, and observational studies required
• Prior experience working in an alliance with another pharma company strongly preferred

Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.